Cargando…
Progress in the Management of Primary Aldosteronism
Primary aldosteronism (PA) is now considered as one of leading causes of secondary hypertension, accounting for 5–10% of all hypertensive patients and more strikingly 20% of those with resistant hypertension. Importantly, those with the unilateral disease could be surgically cured when diagnosed app...
Autores principales: | Morimoto, Ryo, Omata, Kei, Ito, Sadayoshi, Satoh, Fumitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905601/ https://www.ncbi.nlm.nih.gov/pubmed/29534182 http://dx.doi.org/10.1093/ajh/hpy018 |
Ejemplares similares
-
Primary aldosteronism: A Japanese perspective
por: Satoh, Fumitoshi, et al.
Publicado: (2011) -
SAT-058 Histopathological Analysis of Kidneys and Adrenal Glands in the Same Primary Aldosteronism (PA) Patients: Exploring the Mechanisms of Aldosterone Specific Renal Injuries
por: Ogata, Hiroko, et al.
Publicado: (2019) -
Aldosterone-induced cardiac damage in primary aldosteronism depends on its subtypes
por: Higuchi, Satoshi, et al.
Publicado: (2020) -
SUN-496 A Perioperative Risk For Exacerbation of Hypercalcemia in Primary Hyperparathyroidism
por: Tezuka, Yuta, et al.
Publicado: (2019) -
OR02-3 Endocrinological Crosstalk between Calcium Metabolism and Steroidogenesis in Primary Aldosteronism
por: Gao, Xin, et al.
Publicado: (2019)